Assays for Insulin,Proinsulin(S) and C-Peptide

Bliss M . The Discovery of Insulin. Toronto: McClelland and Stewart, 1982, and Edinburgh: Paul Harris Publishing, 1983.

Yalow RS Berson SA . Assay of plasma insulin in human subjects by immunological methods. Nature 1959; 184: 1648–9.

Steiner DF Oyer PE . The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci USA 1967; 57: 473–80.

Steiner DF Cunningham D Spigelman L Aten B . Insulin biosynthesis: evidence for a precursor. Science 1967; 157: 697–700.

Rubenstein AHG Cho S Steiner DF . Evidence for proinsulin in human urine and serum. Lancet 1968; i: 1353–5.

Roth J Gorden P Pastan I . ‘Big insulin’: a new component of plasma insulin detected by immunoassay. Proc Natl Acad Sci USA 1968; 61: 138–45.

Robbins DC Tager HS Rubenstein AH . Biologic and clinical importance of proinsulin. N Engl J Med 1984; 310: 1165–75.

Given BD Cohen RM Shoelson SE Frank BH Rubenstein AH Tager HS . Biochemical and clinical implications of proinsulin conversion intermediates. J Clin Invest 1985; 76: 1398–405.

Temple R Clark PMS Hales CN . Measurement of insulin secretion in Type 2 diabetes: Problems and pitfalls. Diabetic Med 1992; 9: 503–12.

Davidson HW Rhodes CJ Hutton JC . Intraorganelle Ca²⁺ and pH control proinsulin cleavage in the pancreatic β-cell via two distinct site-specific endopeptidases. Nature 1988; 333: 93–6.

Smeekens SP Montag AG Thomas G Albiges-Rizo C Carroll R Benig M Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2 and PC3. Proc Natl Acad Sci USA 1992; 89: 8822–6.

Shennan KI Taylor NA Jermany JL Matthews G Docherty K . Differences in pH optima and calcium requirements for maturation of the prohormone convertase PC2 and PC3 indicates different intracellular locations for these events. J Biol Chem 1995; 270: 1402–7.

Kuzuya H Glix PM Horwitz DL Rubenstein AH Steiner DF Binder C Heterogeneity of circulating C-peptide. J Clin Endocrinol Metab 1977; 44: 952–62.

Kippen AD Cerini F Vadas L Stöcklin A Vu L Offord RE Development of an isotope dilution assay for precise determination of insulin, C-peptide and proinsulin levels in non-diabetic and Type II diabetic individuals with comparison to immunoassay. J Biol Chem 1997; 272: 12513–22.

Tillil H Frank BH Pekar AH Broelsch C Rubenstein AH Polonsky KS . Hypoglycaemic potency and metabolic clearance rate of intravenously administered human proinsulin and metabolites. Endocrinology 1990; 127: 2418–22.

Johansson BL Kernell A Sjöberg S Wahren J . Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type I. J Clin Endocrinol Metab 1993; 77: 376–81.

Abdel-Wahab YHA O'Harte FPM Ratcliffe H McClenaghan NH Barnett CR Flatt PR . Glycation of insulin in the islets of Langerhans of normal and diabetic animals. Diabetes 1996; 45: 1489–96.

Fernandes J Berger R . Hypoglycaemia: principles of diagnosis and treatment in children. Baillieres Clin Endocrinol Metab 1993; 7: 591–609.

Gregory JW Aynsley-Green A . The definition of hypoglycaemia. Baillieres Clin Endocrinol Metab 1993; 7: 587–90.

Marks V Teale JD . Hypoglycaemia in the adult. Baillieres Clin Endocrinol Metab 1993; 7: 705–29.

Service FJ . Hypoglycemic disorders. N Engl J Med 1995; 332: 1144–52.

Berman N Genter P Chou H-F Cortez C Bowsher R Ipp E . Erratic oscillatory characteristics of plasma insulin concentrations in patients with insulinoma: mechanism for unpredictable hypoglycaemia. J Clin Endocrinol Metab 1997; 82: 2899–903.

Kao PC Taylor RL Service FJ . Proinsulin by immunochemiluminometric assay for diagnosis of insulinoma. J Clin Endocrinol Metab 1994; 78: 1048–51.

Gorden P Skarulis MC Roach P Comi RJ Fraker DL Norton JA Plasma proinsulin-like component in insulinoma: A 25-year experience. J Clin Endocrinol Metab 1995; 80: 2884–7.

Ward Platt MP Hawdon JM . Hypoglycaemia in the neonate. Baillieres Clin Endocrinol Metab 1993; 7: 669–82.

Hawdon JM Aynsley-Green Alberti KGMM Ward Platt MP . The role of pancreatic insulin secretion in neonatal glucoregulation. I. Healthy term and preterm infants. Arch Dis Child 1993; 68: 274–9.

Hawdon JM Hubbard M Hales CN Clark PMS . Use of specific immunoradiometric assay to determine preterm neonatal insulin—glucose relations. Arch Dis Child 1995; 73: F166–9.

Ward WK La Cava EC Paquette TL Beard JC Wallum BJ Porte D . Disproportionate elevation of immunoreactive proinsulin in Type 2 (non-insulin dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 1987; 30: 698–702.

Yoshioka N Kuzuya T Matsuda A Taniguchi M Iwamato Y . Serum proinsulin levels at fasting and after oral glucose load in patients with Type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1988; 31: 355–60.

Williams DRR Byrne C Clark PMS Cox L Day NE Rayman G Raised proinsulin concentration as early indicator of β-cell dysfunction. BMJ 1991; 303: 95–6.

Kahn SE Halban PA . Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinaemia of NIDDM. Diabetes 1997; 46: 1725–32.

Rachman J Levy JC Barrow BA Manley SE Turner RC . Relative hyperproinsulinaemia of NIDDM persists despite the reduction of hyperglycaemia with insulin or sulfonylurea therapy. Diabetes 1997; 46: 1557–62.

Kahn SE Leonetti DL Prigeon RL Boyko EJ Bergstrom RW Fujimoto WY . Proinsulin as a marker for the development of NIDDM in Japanese American men. Diabetes 1995; 44: 173–9.

Nijpels G Popp-Snijders C Kostense PJ Bouter LM Heine RJ . Fasting proinsulin and 2-h post glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoon Study. Diabetologia 1996; 39: 113–8.

Haffner SM Gonzalez C Mykkänen L Stern M . Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia 1997; 40: 830–7.

Cohen RM Given BD Licinio-Paixao J Provow SA Rue PA Frank BH Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinaemia. Metabolism 1986; 35: 1137–46.

Yamamato R Iwamato Y Sakura H Yoshioka N Hsieh SD Matsuda A Reduced urinary insulin clearance in patients with abnormal insulinaemia. Diabetes 1987; 36: 602–26.

Røder ME Vissing H Nauck MA . Hyperproinsulinaemia in a three-generation Caucasian family due to mutant proinsulin (Arg⁶⁵ → His) not associated with impaired glucose tolerance. The contribution of mutant proinsulin to insulin bioactivity. J Clin Endocrinol Metab 1996; 81: 1634–40.

Madsbad S Hartling SG Faber OK . C-peptide and proinsulin. In: Alberti KGMM Zimmet P De Fronzo RA Keen H , eds. International Textbook of Diabetes. Chichester: Wiley; 1997:355–81.

Smith S Tolliday U Shakespear R Hartland A Clark PM . Stability of samples for insulin, proinsulin and C-peptide. J Endocrinol 1996; 151 (Suppl): P20.

Feldman JM Chapman BA . Radioimmunoassay of insulin in serum and plasma. Clin Chem 1973; 19: 1250–4.

Brodal BP . The influence of haemolysis on the radioimmunoassay of insulin. Scand J Clin Lab Invest 1971; 28: 287–90.

Cantrell JW Hochholzer JM Frings CS . Effect of haemolysis on the apparent concentration of insulin in plasma. Clin Chem 1972; 18: 1423–5.

O'Rahilly S Burnett MA Smith RF Darley JH Turner RC . Haemolysis affects insulin but not C-peptide immunoassay. Diabetologia 1987; 30: 394–6.

Duckworth WC . Insulin degradation: mechanisms, products and significance. Endocr Rev 1988; 9: 319–45.

Authier F Posner BI Bergeron JJM . Insulin-degrading enzyme. Clin Invest Med 1996; 13: 149–60.

Faber OK Binder C Markussen J Heding LG Naithani VK Kuzuya H Characterization of seven C-peptide antisera. Diabetes 1978; 27(Suppl): 170–7.

Villaume C Beck B . C-peptide comparative radioimmunoassays: a study of three commercial kits. Ann Biol Clin (Paris) 1983; 41: 269–72.

Van Rijn HJM Hoekstra BJL Thijssen JHH . Evaluation of three commercially available C-peptide kits. Ann Clin Biochem 1982; 19: 368–73.

Myrick JE Gunter EW Maggio VL Miller DT Hannon WH . An improved radioimmunoassay of C-peptide and its application in a multiyear study. Clin Chem 1989; 35: 37–42.

Garcia-Webb P Bonser A . Decrease in measured C-peptide immunoreactivity on storage. Clin Chem 1979; 95: 139–41.

Kuzuya T Matsuda A Saito T Yoshida S . Human C-peptide immunoreactivity (CPR) in blood and urine — evaluation of a radioimmunoassay method and its clinical applications. Diabetologia 1976; 12: 511–8.

Bangham DR Mussett MV . Fourth International Standard for insulin. Bull World Health Org 1959; 20: 1209–20.

Kuzuya M Blix PM Horwitz DL Steiner DF Rubenstein AH . Determination of free and total insulin and C-peptide of insulin-treated diabetics. Diabetes 1977; 36: 22–9.

Shoelson S Haneda M Blix P Nanjo A Sanke T Inouye K Three mutant insulins in man. Nature 1983; 302: 540–3.

Linde S Røder ME Hartling SG Binder C . Separation and quantitation of serum proinsulin and proinsulin intermediates in humans. J Chromatogr 1991; 548: 371–80.

Robbins DC Mead PM . Free covalent aggregates of therapeutic insulin in blood of insulin-dependent diabetes. Diabetes 1987; 36: 147–51.

Robbins DC Cooper SM Fineberg SE Mead PM . Antibodies to covalent aggregates of insulin in blood of insulin-using diabetic patients. Diabetes 1987; 36: 838–41.

Given BD Ostrega DM Polonsky KS Baldwin D Kelley RI Rubenstein AH . Hypoglycaemia due to surreptitious injection of insulin. Identification of insulin species by high performance liquid chromatography. Diabetes Care 1991; 14: 544–7.

Ostrega D Polonsky K Nagi D Yudkin J Cox L Clark PMS Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography. Diabetes 1995; 44: 437–40.

Stöcklin R Vu L Vadas L Cerini F Kippen AD Offord RG A stable isotope dilution assay for the in vivo determination of insulin levels in humans by mass spectrometry. Diabetes 1997; 46: 44–50.

Mako ME Starr J Rubenstein AH . Circulating proinsulin in patients with maturity onset diabetes. Am J Med 1997; 63: 865–9.

Krentz AJ Clark PM Cox L Nattrass M . Hyperproinsulinaemia in impaired glucose tolerance. Clin Sci 1993; 85: 97–100.

Temple RC Carrington CA Luzio SD Evans DR Schneider AE Sobey W Insulin deficiency in non-insulin dependent diabetes. Lancet 1989; i: 293–5.

Woodhead JS Addison GM Hales CN . Two site assay of human growth hormone. Horm Metab Res 1971; 3: 59–60.

Hales CN Woodhead JS . Labelled antibodies and their use in the immunoradiometric assay. Methods Enzymol 1980; 70: 334–55.

Kohler G Milstein C . Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–7.

Kohler G Milstein C . Derivation of specific antibody-producing tissue culture and tumour lines by cell fusion. Eur J Immunol 1976; 6: 511–9.

Deberg M Houssa P Frank BH Sodoyez-Goffaux F Sodoyez JC . Highly specific radioimmunoassay for human insulin based on immune exclusion of all insulin precursors. Clin Chem 1998; 44: 1504–13.

Frank BH Pettee JM Zimmerman RE Burck PH . The production of human proinsulin and its transformation into insulin and C-peptide. In: Rich DH Grosse E , eds. Peptides: Synthesis — Structure — Function. Proceedings of the Seventh American Peptide Symposium. Madison, WI, USA: Pierce Chemical Company; 1981:729–38.

Robbins DC Andersen L Bowsher R Chance R Dinesen B Frank B Task Force Report. Report of the American Diabetes Association's Task Force on Standardization of the Insulin Assay. Diabetes 1996; 45: 242–56.

Tolvonen E Hemmilä I Marniemi J Jørgensen PN Zeuthen J Lovgren T . Two-site time-resolved immunofluorometric assay of human insulin. Clin Chem 1986; 32: 637–40.

Ruan K Hashida S Yoshitake S Ishikawa E Wakisaka O Yamamoto Y A more sensitive and less time consuming sandwich enzyme immunoassay for insulin in human serum with less interference. Ann Clin Biochem 1986; 23: 54–8.

Comitti R Racchetti G Guocchi P Marandi E Galeuti YM . A monoclonal based two-site enzyme immunoassay for human insulin. J Immunol Methods 1987; 99: 25–37.

Burgi W Briner M Franken N Kessler A-Ch . One-step sandwich enzyme immunoassay for insulin using monoclonal antibodies. Clin Biochem 1998; 21: 311–4.

Storch MJ Alexopoulos A Kerp L . Evaluation of a solid phase monoclonal antibody based enzyme immunoassay for insulin in human serum. J Immunol Methods 1989; 119: 53–7.

Sobey WJ Beer SF Carrington CA Clark PMS Frank BH Gray IP Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J 1989; 260: 535–41.

Alpha B Cox L Crowther N Clark PMS Hales CN . Sensitive amplified immunoenzymometric assays (IEMA) for human insulin and intact proinsulin. Eur J Clin Chem Clin Biochem 1992; 30: 27–32.

Morris ER Dinesen B Burnett MA Christopher P Bassett PA Manley SE . A new ELISA for specific insulin measurements in Type II diabetic patients. Biochem Soc Trans 1992; 21: 255.

Andersen L Dinesen B Jorgensen PN Poulsen F Roder ME . Enzymeimmunoassay for intact human insulin in serum or plasma. Clin Chem 1993; 39: 578–82.

Storch MJ Marbach P Kerp L . A time-resolved fluoroimmunoassay for human insulin based on two monoclonal antibodies. J Immunol Methods 1993; 157: 197–201.

Sutton PJ Groves CG Lawrence NJ Cull CA Manley SE . Comparison of Linco specific insulin RIA with Pharmacia RIA 100 and specific insulin ELISA. In: Martin SM Halloran SP Green AJE , eds. Proceedings of the ACB National Meeting 1995 May 15-19, Glasgow. London: Association of Clinical Biochemists; 1995:59.

Siohan E Allauzen S Mani JC Demuynak A Rousset M Laprade M Development of a highly sensitive and specific immunoradiometric assay for the measurement of human insulin using monoclonal antibodies. Clin Chem 1996; 42: S233.

Niederhau CM Reinauer H . Evaluation of the IMx insulin analyzer. Clin Chem 1996; 42: S190.

Sampson M Ruddel M Hendricks C Taylor S Elin RJ . Three methods for determination of insulin compared. Clin Chem 1995; 41: S39.

Monti LD Sandoli EP Phan VC Piatti PM Costa S Secchi A A sensitive and reliable method for assaying true human insulin without interaction with human proinsulin-like molecules. Acta Diabetol 1995; 32: 57–63.

Collins S McKeon K Perkins S Saul R . Development of an insulin assay on the Origen® immunoassay system. Clin Chem 1996; 42: S236.

Klee G Furlow B Shellum C Smith T . An automated immuno-chemiluminometric insulin assay for the Access® Immunoassay system. Clin Chem 1995; 41: S34.

Russell A Johnson G . Insulin and free insulin measurements using the Sanofi Diagnostics Pasteur Inc Access® System. Clin Chem 1996; 42: S130.

Lim SJ Kim CK . Homogeneous liposome immunoassay for insulin using phospholipase C from Clostridium perfringens. Anal Biochem 1997; 247: 89–95.

Mecklenburg M Lindbladh C Li H Mosbach K Danielsson B . Enzymatic amplification of a flow-injected thermometric enzyme-linked immunoassay for human insulin. Anal Biochem 1993; 212: 388–93.

Gorden P Roth J . Plasma insulin: fluctuations in the ‘big’ insulin component in man after glucose and other stimuli. J Clin Invest 1969; 48: 2225–34.

Melani F Rubenstein AH Oyer PE Steiner DF . Identification of proinsulin and C-peptide in human serum by a specific immunoassay. Proc Natl Acad Sci USA 1970; 67: 148–55.

Starr JI Juhn DD Rubenstein AH Kitabchi AE . Degradation in serum by insulin specific protease. J Lab Clin Med 1975; 86: 631–7.

Heding LG . Specific and direct radioimmunoassay for human proinsulin in serum. Diabetologia 1977; 13: 467–74.

Rainbow SJ Woodhead JS Yue DK Luzio SD Hales CN . Measurement of human proinsulin by an indirect two-site immunoradiometric assay. Diabetologia 1979; 17: 229–34.

Gray IP Siddle K Docherty K Frank BH Hales CN . Proinsulin in human serum, problems in measurement and interpretation. Clin Endocrinol 1984; 21: 43–7.

Deacon CF Conlon JM . Measurement of circulating human proinsulin concentrations using a proinsulin-specific antiserum. Diabetes 1985; 34: 491–7.

Reaven GM Chen YDI Hollenbeck CB Shaw WHH Ostrega D Polonsky KS . Plasma insulin, C-peptide and proinsulin concentrations in obese and non-obese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 1993; 76: 44–8.

Hartling SG Dinesen B Kappeigard AM Faber OK Binder C . ELISA for human proinsulin. Clin Chim Acta 1986; 156: 289–98.

Ward KW Paquette TL Frank BH Porte D . A sensitive radioimmunoassay for human proinsulin with sequential use of antisera to C-peptide and insulin. Clin Chem 1986; 32: 728–33.

Naylor BA Matthews DR Turner RC . A soluble-phase proinsulin radioimmunoassay and its use in diagnosis of hypoglycaemia. Ann Clin Biochem 1987; 24: 352–63.

Bowsher RR Wolny JD Frank BH . A rapid and sensitive radioimmunoassay for the measurement of proinsulin in human serum. Diabetes 1992; 41: 1084–90.

Hampton SM Beyzavi K Teale D Marks V . A direct assay for proinsulin in plasma and its applications in hypoglycaemia. Clin Endocrinol 1988; 29: 9–16.

Dahir FJ Cook DB Self CH . Amplified enzyme-linked immunoassay for human proinsulin in serum (detection limit: 0·1 pmol/L). Clin Chem 1992; 38: 227–32.

Kjems LL Røder ME Dinesen B Hartling SG Jørgensen PN Binder L . Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies. Clin Chem 1993; 39: 2146–50.

Cook DB Self CH . Determination of one thousandth of an attomole (1 zeptomole) of alkaline phosphatase: application in an immunoassay of proinsulin. Clin Chem 1993; 39: 965–71.

Chevenne D Ruiz J Lohmann L Laudat A Leblanc H Gray IP Immunoradiometric assay of human intact proinsulin applied to patients with Type 2 diabetes, impaired glucose tolerance and hyperandrogenism. Clin Chem 1994; 40: 754–7.

Engling US Missler U Kerner W . Time-resolved immunofluorometric assay for quantifying proinsulin in serum. Clin Chem 1995; 41: 942–3.

Houssa P Dinesen B Deberg M Frank BH Van Schravendijk C Sodoyez-Goffaux F First direct assay for human intact proinsulin. Clin Chem 1998; 44: 1514–9.

Dorrian C . Measurement of Proinsulin [PhD thesis]. Glasgow: University of Glasgow, 1984.

Fiedler R Pulzer F Keller E Kratzsch J . Determination of intact proinsulin in human serum using the DRG ELISA. Clin Chem 1996; 42: S122.

Ashby JP Frier BM . Circulating C-peptide: measurement and clinical application. Ann Clin Biochem 1981; 18: 125–30.

Bonser AM Garcia-Webb P . C-peptide measurement and its clinical usefulness: a review. Ann Clin Biochem 1981; 18: 200–6.

Kuzuya H Blix PM Horwitz DL Rubenstein AH Steiner DF Faber OK Heterogeneity of circulating human C-peptide. Diabetes 1978; 27(Suppl 1): 184–91.

Heding L . Radioimmunological determination of human C-peptide in serum. Diabetologia 1975; 11: 541–8.

Caygill CPJ Gaines Das RE Bangham DR . Use of a common standard for comparison of insulin C-peptide measurements by different laboratories. Diabetologia 1980; 18: 197–204.

Koskonen P . Non transferability of C-peptide measurements with various commercial radioimmunoassay reagents. Clin Chem 1988; 34: 1575–8.

Saelsen L Tronier B Madsbad S Christensen NJ . A rapid method for determination of human C-peptide in plasma. Clin Chim Acta 1991; 196: 1–6.

Kao PC Taylor RL Heser DW . C-peptide immunochemiluminometric assay developed from two seemingly identical polyclonal antisera. Ann Clin Lab Sci 1992; 22: 307–316.

Swanson KH Haven MC . Evaluation of C-peptide by chemiluminescent immunoassay on the Immulite analyser. Clin Chem 1996; 42: S117.

Robinson L Igarashi K Kanai A Kolarik S . Automated assay for C-peptide on the AIA-series of immunoassay analyzers. Clin Chem 1996; 42: S171.

Horwitz DL Rubenstein AH Katz Al . Quantitation of human pancreatic β-cell function by immunoassay of C-peptide in urine. Diabetes 1977; 26: 30–5.

Kaneko T Munemura M Oka H Oda T Suzuki S Yasuda H Demonstration of C-peptide immunoreactivity in various body fluids and clinical evaluation of the determination of urinary C-peptide immunoreactivity. Endocrinol Japon 1975; 22: 207–12.

Meistas MT Zadik Z Margolin S Kowarski AA . Correlation of urinary excretion of C-peptide with the integrated concentration and secretion rate of insulin. Diabetes 1981; 30: 639–43.

Bristow AF Gaines Das RE Bangham DR . World Health Organization standards for highly purified human, porcine and bovine insulins. J Biol Stand 1988; 16: 165–78.

Vølund A Brange J Drejer K Jensen I Markussen J Ribel U In vitro and in vivo potency of insulin analogues designed for clinical use. Diabet Med 1991; 8: 839–47.

Vølund A . Conversion of insulin units to SI units. Am J Clin Nutr 1993; 58: 714–5.

Clark PM . Sources of error in the measurement of insulin, C-peptide and proinsulin. Diabet Med 1995; 12: S38.

Boscato LM Stuart MC . Incidence and specificity of interference in two-site immunoassays. Clin Chem 1986; 32: 1491–5.

Goldman J Baldwin D Rubenstein AH Klink DD Blackard WG Fisher LK Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycaemia. J Clin Invest 1979; 63: 1050–9.

Kurz AB . Antibodies to insulin. In: Pickup JC , ed. Brittle Diabetes. Oxford: Blackwell Scientific; 1985:60–7.

Greenbaum CJ Palmer JP Kuglin B Kolb H, and participating laboratories. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: Results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement. J Clin Endocrinol Metab 1992; 74: 1040–4.

Keilacker H Rjasanouski I Besch W Kohnert KD . Autoantibodies to insulin and to proinsulin in Type I diabetic patients and in at-risk probands differentiate only little between both antigens. Horm Metab Res 1995; 27: 90–4.

Arnquist H Olsson PO von Schenck H . Free and total insulin as determined after precipitation with polyethylene glycol: analytical characteristics and effects of sample handling and storage. Clin Chem 1987; 33: 93–6.

Rudkowski R Antony G . The effect of immediate polyethylene glycol precipitation on free insulin measurements in diabetic patients with insulin antibodies. Diabetes 1986; 35: 253–7.

Hanning I Home PD Alberti KGMM . Measurement of free insulin concentrations: the influence of the timing of extraction of insulin antibodies. Diabetologia 1985; 28: 831–5.

Spencer CA Takeuchi M Kazarosyan M . Current status and performance goals for serum thyroglobulin assays. Clin Chem 1996; 42: 164–73.

Sapin R . Anti-insulin antibodies in insulin immunometric assays: a still possible pitfall. Eur J Clin Chem Clin Biochem 1997; 35: 365–7.

Andersen L Dinesen B Jorgensen PN Poulsen F Røder ME . Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993; 39: 578–82.

O'Rahilly S Turner RC Matthews DR . Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 1998; 318: 1225–30.

Faber OK Hagen C Binder C Markussen J Naithani VK Blix PM Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest 1978; 62: 197–203.

Amiel SA Sherwin RS Simonson DC Lauritano AA Tamborlane WV . Impaired insulin action in puberty: a contributory factor to poor glycaemic control in adolescents with diabetes. N Engl J Med 1986; 315: 215–9.

Shimokata H Muller DC Fleg JL Sorkin J Ziemba AW Andres R . Age as independent determinant of glucose tolerance. Diabetes 1991; 40: 44–51.

Clark MG Rattigan S Clark DG . Obesity with insulin resistance: experimental insights. Lancet 1983; ii: 1236–40.

Krotkiewski M Lonnroth P Mandroukas K Wroblewski Z Rebuffe-Scrive M Holm G The effect of physical training on insulin secretion and effectiveness and on glucose metabolism in obesity and Type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1985; 28: 881–90.

Diamond MP Simonson DL De Fronzo RA . Menstrual cyclicity has a profound effect on glucose homeostasis. Fertil Steril 1989; 52: 204–8.

Kuhl C . Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management. Diabetes 1991; 40(Suppl 2): 18–24.

McGuire EAH Helderman JH Tobin JD Andres R Berman M . Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 1976; 41: 565–73.

Beer SF Parr JH Temple RC Hales CN . The effect of thyroid disease on proinsulin and C-peptide levels. Clin Endocrinol 1989; 30: 379–83.

Ballmann M Hartmann H Deacon CF Schmidt WE Conlon JM Creutzfeldt W . Hypersecretion of proinsulin does not explain the hyperinsulinaemia of patients with liver cirrhosis. Clin Endocrinol 1986; 25: 351–61.

Kahn SE McCulloch DK Porte D . Insulin secretion in the normal and diabetic human. In: Alberti KGMM Zimmet P De Fronzo RA Keen H , eds. International Textbook of Diabetes Mellitus, 2nd edn. Chichester: Wiley, 1997:337–53.

Bergman RN Finegood D Ader M . Assessment of insulin sensitivity in vivo. Endocr Rev 1985; 6: 45–86.

Davis SN Piatti PM Monti L Moller N Ng LL Coppack S A comparison of four methods for assessing in vivo β-cell function in normal, obese and non-insulin-dependent diabetic man. Diabetes Res 1992; 19: 107–11.

Davis SN Monti L Piatti PM Moller N Ng L Coppack S Estimation of insulin action in normal, obese and NIDDM man: Comparison of insulin and glucose infusion test, CIGMA, mimimal model and glucose clamp techniques. Diabetes Res 1993; 23: 1–18.

Tritos NA Mantzoros CS . Syndromes of severe insulin resistance. J Clin Endocrinol Metab 1998; 83: 3025–30.

Walker M Fulcher GR Alberti KGMM . The assessment of insulin action in vivo. In: Alberti KGMM Zimmet P De Fronzo RA Keen H , eds. International Textbook of Diabetes Mellitus, 2nd edn. Chichester: Wiley, 1997:595–610.

Matthews DR Hosker JP Rudenski AS Naylor BA Treacher DF Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–9.

Hosker JP Matthews DR Rudenski AS Burnett MA Darling P Bown EG Continuous infusion of glucose with model assessment: measurement of insulin resistance and β-cell function in man. Diabetologia 1985; 28: 401–11.

Service FJ O'Brien PC Kao PC Young WF . C-peptide suppression test: effects of gender, age and body mass index: implications for the diagnosis of insulinoma. J Clin Endocrinol Metab 1992; 74: 204–10.

Faber OK Binder C . C-peptide response to glucagon. A test for the residual β-cell function in diabetes mellitus. Diabetes 1977; 26: 605–10.